DJIA 16,492.28 140.90 0.86%
NASDAQ 4,782.09 32.11 0.68%
S&P 500 1,966.94 18.08 0.93%
market minute promo

Amgen (NASDAQ: AMGN)

151.13 -1.16 (-0.76%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AMGN $151.13 -0.76%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $152.68
Previous Close $152.29
Daily Range $151.10 - $154.12
52-Week Range $127.67 - $181.81
Market Cap $114.6B
P/E Ratio 20.17
Dividend (Yield) $3.16 (2.1%)
Ex-Dividend Date
Dividend Pay Date
08/13/15
09/08/15
Volume 995,133
Average Daily Volume 4,287,793
Current FY EPS $9.72

Sector

Healthcare

Industry

Drug Makers

Amgen (AMGN) Description

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. Website: http://www.amgen.com/

News & Commentary

Amgen Inc.'s FDA Approval Holds Blockbuster Potential

Amgen's new LDL-lowering cholesterol medication Repatha gets the go-ahead from the FDA.

The Zacks Analyst Blog Highlights: Amgen, ARIAD, Celgene, Amicus and Alnylam

Insider Trading Alert - AMGN, RDNT And CHD Traded By Insiders

Premarket Biotech Digest: Hep C Vaccine, Big Month For Arrowhead, Gilead's Positive Phase III For F/

Premarket Biotech Digest: Hep C Vaccine, Big Month For Arrowhead, Gilead's Positive Phase III For F/TAF Combo

Wall Street Breakfast: Markets Rally Ahead Of ECB Policy Meeting

Amgen, Novartis Team Up; Bone Drug Positive in Phase III

Regeneron and Sanofi Present Encouraging Praluent Data

Notable ETF Outflow Detected - XLV, GILD, AGN, AMGN

Amgen's Next-Generation Cholesterol Drug Is Approved, but Pricing Is a Huge Concern

Repatha gets the green light from the Food and Drug Administration, but pharmacy benefit managers and insurers are ready to give PCSK9 inhibitors the red light.

Premarket Biotech Digest: Anti-CD Antigen Therapy, Geron Files S-3, 3 MAAs In EU

See More AMGN News...

AMGN's Top Competitors

AMGN $151.13 (-0.76%)
Current stock: AMGN
GILD $103.38 (-0.85%)
Current stock: GILD
CELG $119.68 (0.08%)
Current stock: CELG
$0.00 (0.00%)
Current stock: